CYP19A1 and breast cancer: Interestingly, a clinical trial is evaluating the impact of obesity on the efficacy of adjuvant endocrine therapy with aromatase inhibitors, and the BWEL study assesses whether weight loss in overweight and obese women may prevent BC’s recurrence.